Issued Patents All Time
Showing 1–25 of 33 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12338455 | RNA-guided nucleases and active fragments and variants thereof and methods of use | Alexandra Briner Crawley, Tyson D. Bowen, Michael Coyle, Tedd D. Elich | 2025-06-24 |
| 12264330 | Recombinant type I CRISPR-Cas system and uses thereof for killing target cells | Claudio Hidalgo Cantabrana | 2025-04-01 |
| 12264313 | Recombinant type I CRISPR-Cas system and uses thereof for genome modification and alteration of expression | Claudio Hidalgo Cantabrana | 2025-04-01 |
| 12203123 | Recombinant type I CRISPR-Cas system and uses thereof for screening for variant cells | Claudio Hidalgo Cantabrana | 2025-01-21 |
| 11926843 | RNA-guided nucleases and active fragments and variants thereof and methods of use | Alexandra Briner Crawley, Tyson D. Bowen, Michael Coyle, Tedd D. Elich | 2024-03-12 |
| 11753651 | Cas9 proteins and guiding features for DNA targeting and genome editing | Alexandra Briner Crawley | 2023-09-12 |
| 11680259 | Recombinant type I CRISPR-CAS system | Claudio Hidalgo-Cantabrana | 2023-06-20 |
| 11542466 | Methods and compositions for delivery of CRISPR based antimicrobials | Jan Peter Van Pijkeren | 2023-01-03 |
| 11499169 | Compositions and methods related to a type-II CRISPR-Cas system in Lactobacillus buchneri | Alexandra Briner Crawley | 2022-11-15 |
| 11261451 | Methods for screening bacteria, archaea, algae, and yeast using CRISPR nucleic acids | Kurt SELLE | 2022-03-01 |
| 11162114 | RNA-guided nucleases and active fragments and variants thereof and methods of use | Alexandra Briner Crawley, Tyson D. Bowen, Michael Coyle, Tedd D. Elich | 2021-11-02 |
| 10787654 | Methods and compositions for sequence guiding Cas9 targeting | Kurt SELLE, Alexandra E. Briner | 2020-09-29 |
| 10711267 | Recombinant type I CRISPR-Cas system | Claudio Hidalgo-Cantabrana | 2020-07-14 |
| 10662227 | Bifidobacteria CRISPR sequences | Philippe Horvath, Dennis Romero, Lindsay L. Traeger | 2020-05-26 |
| 10640778 | Method of modulating cell resistance | Patrick Boyaval, Christophe Fremaux, Philippe Horvath, Dennis Romero | 2020-05-05 |
| 10584358 | Compositions and methods related to a type-II CRISPR-Cas system in Lactobacillus buchneri | Alexandra E. Briner | 2020-03-10 |
| 10543239 | Lactic acid bacteria and bifidobacteria for treating endotoxemia | Remy Burcelin, Didier Carcano, Pierre Desreumaux, Sampo Lahtinen, Nina Rautonen +2 more | 2020-01-28 |
| 10450584 | Cas9 proteins and guiding features for DNA targeting and genome editing | Alexandra E. Briner | 2019-10-22 |
| 10136649 | Methods for screening bacteria, archaea, algae, and yeast using CRISPR nucleic acids | Kurt SELLE | 2018-11-27 |
| 10066233 | Method of modulating cell resistance | Patrick Boyaval, Christophe Fremaux, Philippe Horvath, Dennis Romero | 2018-09-04 |
| 9951342 | Cultures with improved phage resistance | Christophe Fremaux, Phillippe Horvath, Dennis Romero, Patrick Boyaval | 2018-04-24 |
| 9879269 | Method for modulating resistance | Patrick Boyaval, Philippe Horvath, Christophe Fremaux, Dennis Romero | 2018-01-30 |
| 9816140 | Tagged microorganisms and methods of tagging | Christophe Fremaux, Philippe Horvath, Dennis Romero | 2017-11-14 |
| 9399801 | Tagged microorganisms and methods of tagging | Christophe Fremaux, Philippe Horvath, Dennis Romero | 2016-07-26 |
| 9259447 | Lactic acid bacteria and bifidobacteria for treating endotoxemia | Remy Burcelin, Didier Carcano, Pierre Desreumaux, Sampo Lahtinen, Nina Rautonen +2 more | 2016-02-16 |